Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carvedilol SR vs Carvedilol IR in Essential Hypertension (Phase 3)
KCT0000646Phase 3Recruiting
- Sponsor
- Chong Kun Dang
- Start
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of carvedilol in essential hypertension, sponsored by Chong Kun Dang. Started Dec 2012; status: recruiting.
02
Drugs
carvedilol
03
Conditions
essential hypertension
Beyond the preview
Go deeper on KCT0000646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000646.